- Home
- LXEO vs ECX Comparison
LXEO vs ECX Comparison
Compare LXEO & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LXEO | ECX |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | United Kingdom |
| Employees | N/A | 1432 |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.5M | 388.7M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | LXEO | ECX |
|---|---|---|
| Price | $4.75 | $1.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $18.44 | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 1.6M |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $654,000.00 | N/A |
| Revenue This Year | N/A | $819.14 |
| Revenue Next Year | N/A | $32.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.60 | $0.88 |
| 52 Week High | $10.99 | $2.70 |
Technical Indicators
Market Signals| Indicator | LXEO | ECX |
|---|---|---|
| Relative Strength Index (RSI) | 47.42 | 45.11 |
| Support Level | $4.27 | $0.93 |
| Resistance Level | $5.34 | $1.30 |
| Average True Range (ATR) | 0.33 | 0.10 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 36.19 | 41.18 |
Price Performance
Historical ComparisonAbout LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
About ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the Peoples Republic of China. The companies core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.